{
    "data": [
        {
            "id": "67a35c869d57a90001d54d6b",
            "title": "Top Wall Street Forecasters Revamp Arm Holdings Price Expectations Ahead Of Q3 Earnings",
            "description": " ",
            "image": "https://www.benzinga.com/files/images/story/2025/02/05/Arm-Holdings-Plc--ADR-ARM.jpeg",
            "link": "https://www.benzinga.com/analyst-ratings/price-target/25/02/43491945/top-wall-street-forecasters-revamp-arm-holdings-price-expectations-ahead-of-q3-earnings",
            "pub_date": "2025-02-05 20:41:45",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "67a35cfd9d57a90001d54d92",
            "title": "These Analysts Revise Their Forecasts On Snap After Q4 Results",
            "description": " ",
            "image": "https://www.benzinga.com/files/images/story/2025/02/05/Analysts.jpeg",
            "link": "https://www.benzinga.com/25/02/43491978/these-analysts-revise-their-forecasts-on-snap-after-q4-results",
            "pub_date": "2025-02-05 20:43:44",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "67a35d169d57a90001d54d9f",
            "title": "Novo Nordisk Q4 Earnings: Wegovy Sales More Than Double, Seeks Regulatory Approval For Hybrid Weight Loss Drug In 2026",
            "description": "Novo Nordisk reported Q4 sales of $11.96 billion, beating estimates. The company plans a new phase 3 trial for CagriSema in 2025, with results expected in Q1.",
            "image": "https://www.benzinga.com/files/images/story/2025/02/05/ozempic-shutter.jpeg",
            "link": "https://www.benzinga.com/25/02/43491991/novo-nordisk-records-more-than-double-wegovy-sales-in-q4-seeks-regulatory-approval-for-hybrid-weight-loss-drug-in-2026",
            "pub_date": "2025-02-05 20:44:10",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "67a35b4f9d57a90001d54cd4",
            "title": "Meta AI Models &#39;Clearly Behind&#39; DeepSeek, Says Analysts After Mark Zuckerberg Admitted DeepSeek Did Some Novel Things &#39;We&#39;re Still Digesting&#39;",
            "description": "Piper Sandler&#39;s research dated Feb. 4 has revealed a less optimistic outlook for Meta Platforms&#39; position in the artificial intelligence race.",
            "image": "https://www.benzinga.com/files/images/story/2025/02/05/Meta-Platforms-Inc-.jpeg",
            "link": "https://www.benzinga.com/general/market-summary/25/02/43491799/meta-ai-models-clearly-behind-deepseek-says-analysts-after-mark-zuckerberg-admitted-deepseek-did-some-novel-things-were-still-digesting",
            "pub_date": "2025-02-05 20:36:26",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "67a35baf9d57a90001d54d23",
            "title": "These Analysts Raise Their Forecasts On 8x8 Following Q3 Results",
            "description": " ",
            "image": "https://www.benzinga.com/files/images/story/2025/02/05/Munich--Bavaria--Germany---March-31-2023.jpeg",
            "link": "https://www.benzinga.com/25/02/43491871/these-analysts-raise-their-forecasts-on-8x8-following-q3-results",
            "pub_date": "2025-02-05 20:38:11",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}